Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Author response: Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Aug 21;91(8):373-374. doi: 10.1212/WNL.0000000000006042. No abstract available.

PMID:
30126885
2.

Identifying priority outcomes that influence selection of disease-modifying therapies in MS.

Day GS, Rae-Grant A, Armstrong MJ, Pringsheim T, Cofield SS, Marrie RA.

Neurol Clin Pract. 2018 Jun;8(3):179-185. doi: 10.1212/CPJ.0000000000000449.

PMID:
30105155
3.

Using antipsychotics for behavioral problems in children.

Shafiq S, Pringsheim T.

Expert Opin Pharmacother. 2018 Sep;19(13):1475-1488. doi: 10.1080/14656566.2018.1509069. Epub 2018 Aug 13.

PMID:
30102079
4.

The prevalence of diagnosed obsessive compulsive disorder and associated comorbidities: A population-based Canadian study.

Osland S, Arnold PD, Pringsheim T.

Psychiatry Res. 2018 Oct;268:137-142. doi: 10.1016/j.psychres.2018.07.018. Epub 2018 Jul 11.

PMID:
30025284
5.

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study.

Hirsch L, Patten SB, Bresee L, Jette N, Pringsheim T.

BJPsych Open. 2018 Jul;4(4):256-261. doi: 10.1192/bjo.2018.33.

6.

Antipsychotic Drug-Induced Movement Disorders: A Forgotten Problem?

Pringsheim T, Barnes TRE.

Can J Psychiatry. 2018 Jan 1:706743718786702. doi: 10.1177/0706743718786702. [Epub ahead of print] No abstract available.

PMID:
29950107
7.

Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.

Osland ST, Steeves TD, Pringsheim T.

Cochrane Database Syst Rev. 2018 Jun 26;6:CD007990. doi: 10.1002/14651858.CD007990.pub3. Review.

PMID:
29944175
8.

Miming neurological syndromes improves medical student's long-term retention and delayed recall of neurology.

Roze E, Worbe Y, Louapre C, Méneret A, Delorme C, McGovern E, Ruiz M, Capron J, Le Bouc R, Epelbaum S, Alamowitch S, Duguet A, Renaud MC, Palombi O, Pringsheim TM, Flamand-Roze C, Steichen O.

J Neurol Sci. 2018 Aug 15;391:143-148. doi: 10.1016/j.jns.2018.06.003. Epub 2018 Jun 7.

PMID:
29910128
9.

Movement Disorders Associated With Antipsychotic Medication in People With Schizophrenia: An Overview of Cochrane Reviews and Meta-Analysis.

Martino D, Karnik V, Osland S, Barnes TRE, Pringsheim TM.

Can J Psychiatry. 2018 Jan 1:706743718777392. doi: 10.1177/0706743718777392. [Epub ahead of print]

PMID:
29758999
10.

The lesser of two evils: a qualitative study of quetiapine prescribing by family physicians.

Kelly M, Dornan T, Pringsheim T.

CMAJ Open. 2018 Apr 30;6(2):E191-E196. doi: 10.9778/cmajo.20170145.

11.

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345.

PMID:
29686117
12.

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T.

Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347.

PMID:
29686116
13.

The Assessment and Treatment of Antipsychotic-Induced Akathisia.

Pringsheim T, Gardner D, Addington D, Martino D, Morgante F, Ricciardi L, Poole N, Remington G, Edwards M, Carson A, Barnes TRE.

Can J Psychiatry. 2018 Jan 1:706743718760288. doi: 10.1177/0706743718760288. [Epub ahead of print]

14.

Antipsychotic Drug-Induced Movement Disorders: A Forgotten Problem?

Pringsheim T, Barnes TRE.

Can J Psychiatry. 2018 Jan 1:706743718772526. doi: 10.1177/0706743718772526. [Epub ahead of print] No abstract available.

PMID:
29685067
15.

Effects of depression and anxiety on quality of life in five common neurological disorders.

Prisnie JC, Sajobi TT, Wang M, Patten SB, Fiest KM, Bulloch AGM, Pringsheim T, Wiebe S, Jette N.

Gen Hosp Psychiatry. 2018 May - Jun;52:58-63. doi: 10.1016/j.genhosppsych.2018.03.009. Epub 2018 Apr 4.

PMID:
29684713
16.

Alternating hemiplegia of childhood: Clinical case and video description.

Au K, Pringsheim T.

Neurol Clin Pract. 2017 Oct;7(5):413-414. doi: 10.1212/CPJ.0000000000000343. No abstract available.

PMID:
29620090
17.

Barriers and Facilitators for Guidelines with Depression and Anxiety in Parkinson's Disease or Dementia.

Goodarzi Z, Hanson HM, Jette N, Patten S, Pringsheim T, Holroyd-Leduc J.

Can J Aging. 2018 Jun;37(2):185-199. doi: 10.1017/S0714980818000053. Epub 2018 Apr 5.

PMID:
29618389
18.

Validating screening tools for depression in Parkinson's disease.

Kadhim S, Pringsheim T, Le A, Fiest KM, Patten SB, Prisnie JC, Gill S, Bulloch AGM, Hu B, Jette N.

Mov Disord. 2018 Jul;33(7):1184-1186. doi: 10.1002/mds.27371. Epub 2018 Mar 24. No abstract available.

PMID:
29573354
19.

Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada.

Chen W, Cepoiu-Martin M, Stang A, Duncan D, Symonds C, Cooke L, Pringsheim T.

Clin Drug Investig. 2018 May;38(5):449-455. doi: 10.1007/s40261-018-0626-4.

PMID:
29453686
20.

Clinical Utility of Screening for Anxiety and Depression in Children with Tourette Syndrome.

Marwitz L, Pringsheim T.

J Can Acad Child Adolesc Psychiatry. 2018 Jan;27(1):15-21. Epub 2018 Jan 1.

21.

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A.

Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.

PMID:
29282327
22.

Tourette syndrome and other chronic tic disorders: an update on clinical management.

Martino D, Pringsheim TM.

Expert Rev Neurother. 2018 Feb;18(2):125-137. doi: 10.1080/14737175.2018.1413938. Epub 2017 Dec 8.

PMID:
29219631
23.

Detecting anxiety in individuals with Parkinson disease: A systematic review.

Mele B, Holroyd-Leduc J, Smith EE, Pringsheim T, Ismail Z, Goodarzi Z.

Neurology. 2018 Jan 2;90(1):e39-e47. doi: 10.1212/WNL.0000000000004771. Epub 2017 Dec 6.

PMID:
29212828
24.

Neurology and mental health.

Pringsheim T.

Neurol Clin Pract. 2017 Apr;7(2):96-97. doi: 10.1212/CPJ.0000000000000345. No abstract available.

25.

Functional movement disorders: Five new things.

Pringsheim T, Edwards M.

Neurol Clin Pract. 2017 Apr;7(2):141-147. doi: 10.1212/CPJ.0000000000000350.

26.

Feasibility and Relevance of Antipsychotic Safety Monitoring in Children With Tourette Syndrome: A Prospective Longitudinal Study.

Pringsheim T, Ho J, Sarna JR, Hammer T, Patten S.

J Clin Psychopharmacol. 2017 Oct;37(5):498-504. doi: 10.1097/JCP.0000000000000760.

PMID:
28816926
27.

Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics.

Martino D, Ganos C, Pringsheim TM.

Int Rev Neurobiol. 2017;134:1461-1490. doi: 10.1016/bs.irn.2017.05.006. Epub 2017 Jun 9. Review.

PMID:
28805580
28.

Canadian Schizophrenia Guidelines: Introduction and Guideline Development Process.

Pringsheim T, Addington D.

Can J Psychiatry. 2017 Sep;62(9):586-593. doi: 10.1177/0706743717719897. Epub 2017 Aug 9. Review.

29.

Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.

Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, Jackson K, Pringsheim T, Addington D.

Can J Psychiatry. 2017 Sep;62(9):635-647. doi: 10.1177/0706743717720197. Epub 2017 Aug 2. Review.

30.

Physical Health and Drug Safety in Individuals with Schizophrenia.

Pringsheim T, Kelly M, Urness D, Teehan M, Ismail Z, Gardner D.

Can J Psychiatry. 2017 Sep;62(9):673-683. doi: 10.1177/0706743717719898. Epub 2017 Jul 18. Review.

31.

Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies.

Hirsch L, Yang J, Bresee L, Jette N, Patten S, Pringsheim T.

Drug Saf. 2017 Sep;40(9):771-781. doi: 10.1007/s40264-017-0543-0. Review.

PMID:
28585153
32.

Smoking, alcohol and drug use in youth and adults with attention-deficit hyperactivity disorder.

Osland S, Hirsch L, Pringsheim T.

BJPsych Open. 2017 May 19;3(3):141-146. doi: 10.1192/bjpo.bp.116.004317. eCollection 2017 May.

33.

Tics in the Pediatric Population: Pragmatic Management.

Ganos C, Martino D, Pringsheim T.

Mov Disord Clin Pract. 2017 Mar-Apr;4(2):160-172. doi: 10.1002/mdc3.12428. Epub 2016 Nov 11. Review.

34.

Reply to "Screening tools for tic disorders - Focus on development or implementation?"

Martino D, Pringsheim TM.

Mov Disord. 2017 Jun;32(6):947. doi: 10.1002/mds.26986. Epub 2017 Apr 24. No abstract available.

PMID:
28436554
35.

Determinants of neurological disease: Synthesis of systematic reviews.

Krewski D, Barakat-Haddad C, Donnan J, Martino R, Pringsheim T, Tremlett H, van Lieshout P, Walsh SJ, Birkett NJ, Gomes J, Little J, Bowen S, Candundo H, Chao TK, Collins K, Crispo JAG, Duggan T, El Sherif R, Farhat N, Fortin Y, Gaskin J, Gupta P, Hersi M, Hu J, Irvine B, Jahanfar S, MacDonald D, McKay K, Morrissey A, Quach P, Rashid R, Shin S, Sikora L, Tkachuk S, Taher MK, Wang MD, Darshan S, Cashman NR.

Neurotoxicology. 2017 Jul;61:266-289. doi: 10.1016/j.neuro.2017.04.002. Epub 2017 Apr 12. Review.

PMID:
28410962
36.

Assessment and Treatment of Oppositional Behaviour, Conduct Problems, and Aggression in Children and Adolescents: Creation and Dissemination of a National Curriculum.

Pringsheim T, Andrade B, Doja A, Gorman DA.

Can J Psychiatry. 2017 Jun;62(6):431-432. doi: 10.1177/0706743716679818. Epub 2017 Apr 7. No abstract available.

37.

Tic Severity and Treatment in Children: The Effect of Comorbid Attention Deficit Hyperactivity Disorder and Obsessive Compulsive Behaviors.

Pringsheim T.

Child Psychiatry Hum Dev. 2017 Dec;48(6):960-966. doi: 10.1007/s10578-017-0718-z.

PMID:
28289952
38.

Health status, health related behaviours and chronic health indicators in people with Tourette Syndrome: A Canadian population-based study.

Yang J, Hirsch L, Osland S, Martino D, Jette N, Roberts JI, Pringsheim T.

Psychiatry Res. 2017 Apr;250:228-233. doi: 10.1016/j.psychres.2017.02.002. Epub 2017 Feb 2.

PMID:
28167437
39.

Risk factors for the onset and progression of Huntington disease.

Chao TK, Hu J, Pringsheim T.

Neurotoxicology. 2017 Jul;61:79-99. doi: 10.1016/j.neuro.2017.01.005. Epub 2017 Jan 20. Review.

PMID:
28111121
40.

Systematic review of severity scales and screening instruments for tics: Critique and recommendations.

Martino D, Pringsheim TM, Cavanna AE, Colosimo C, Hartmann A, Leckman JF, Luo S, Munchau A, Goetz CG, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2017 Mar;32(3):467-473. doi: 10.1002/mds.26891. Epub 2017 Jan 10. Review.

41.

Is the prevalence of major depression increasing in the Canadian adolescent population? Assessing trends from 2000 to 2014.

Wiens K, Williams JV, Lavorato DH, Duffy A, Pringsheim TM, Sajobi TT, Patten SB.

J Affect Disord. 2017 Mar 1;210:22-26. doi: 10.1016/j.jad.2016.11.018. Epub 2016 Nov 23.

PMID:
28012349
42.

Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, Pringsheim T, Lorenzetti DL, Jetté N.

Neurology. 2017 Jan 17;88(3):296-303. doi: 10.1212/WNL.0000000000003509. Epub 2016 Dec 16. Review. Erratum in: Neurology. 2017 Aug 8;89(6):642.

43.

Guidelines for dementia or Parkinson's disease with depression or anxiety: a systematic review.

Goodarzi Z, Mele B, Guo S, Hanson H, Jette N, Patten S, Pringsheim T, Holroyd-Leduc J.

BMC Neurol. 2016 Nov 25;16(1):244. Review.

45.

A 32-year-old woman with headache.

Davenport WJ, Pringsheim TM.

CMAJ. 2016 Dec 6;188(17-18):E533-E534. Epub 2016 Oct 11. No abstract available.

46.

Genetic variation associated with the occurrence and progression of neurological disorders.

Little J, Barakat-Haddad C, Martino R, Pringsheim T, Tremlett H, McKay KA, van Lieshout P, Walsh SJ, Gomes J, Krewski D.

Neurotoxicology. 2017 Jul;61:243-264. doi: 10.1016/j.neuro.2016.09.018. Epub 2016 Oct 3. Review.

PMID:
27713094
47.

Clinical Complexity and Use of Antipsychotics and Restraints in Long-Term Care Residents with Parkinson's Disease.

Heckman GA, Crizzle AM, Chen J, Pringsheim T, Jette N, Kergoat MJ, Eckel L, Hirdes JP.

J Parkinsons Dis. 2017;7(1):103-115. doi: 10.3233/JPD-160931.

PMID:
27689617
48.

The International Incidence of Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Nguyen R, Fiest KM, McChesney J, Kwon CS, Jette N, Frolkis AD, Atta C, Mah S, Dhaliwal H, Reid A, Pringsheim T, Dykeman J, Gallagher C.

Can J Neurol Sci. 2016 Nov;43(6):774-785. Epub 2016 Sep 27. Review.

PMID:
27670907
49.

The prevalence of diagnosed tourette syndrome in Canada: A national population-based study.

Yang J, Hirsch L, Martino D, Jette N, Roberts J, Pringsheim T.

Mov Disord. 2016 Nov;31(11):1658-1663. doi: 10.1002/mds.26766. Epub 2016 Aug 22.

PMID:
27548401
50.

Treatment of Cluster Headache: The American Headache Society Evidence-Based Guidelines.

Robbins MS, Starling AJ, Pringsheim TM, Becker WJ, Schwedt TJ.

Headache. 2016 Jul;56(7):1093-106. doi: 10.1111/head.12866. Review.

PMID:
27432623

Supplemental Content

Loading ...
Support Center